{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T19:58:55Z","timestamp":1765742335509},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s10552-009-9365-4","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T01:07:17Z","timestamp":1243472837000},"page":"1387-1396","source":"Crossref","is-referenced-by-count":30,"title":["Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women\u2014implications for vaccination"],"prefix":"10.1007","volume":"20","author":[{"given":"Richard A.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Fornika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Moravan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Amirabbasi-Beik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Kollar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Towers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasenka","family":"Matisic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Brooks-Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,29]]},"reference":[{"key":"9365_CR1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319. doi: 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","journal-title":"J Pathol"},{"key":"9365_CR2","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/425907","volume":"190","author":"N Munoz","year":"2004","unstructured":"Munoz N, Mendez F, Posso H et al (2004) Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 190:2077\u20132087. doi: 10.1086\/425907","journal-title":"J Infect Dis"},{"key":"9365_CR3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"DM Harper","year":"2004","unstructured":"Harper DM, Franco EL, Wheeler C et al (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757\u20131765. doi: 10.1016\/S0140-6736(04)17398-4","journal-title":"Lancet"},{"key":"9365_CR4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","volume":"367","author":"DM Harper","year":"2006","unstructured":"Harper DM, Franco EL, Wheeler CM et al (2006) Sustained efficacy up to 4.5\u00a0years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367:1247\u20131255. doi: 10.1016\/S0140-6736(06)68439-0","journal-title":"Lancet"},{"key":"9365_CR5","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","author":"LA Koutsky","year":"2002","unstructured":"Koutsky LA, Ault KA, Wheeler CM et al (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645\u20131651. doi: 10.1056\/NEJMoa020586","journal-title":"N Engl J Med"},{"key":"9365_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"LL Villa","year":"2005","unstructured":"Villa LL, Costa RL, Petta CA et al (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6:271\u2013278. doi: 10.1016\/S1470-2045(05)70101-7","journal-title":"Lancet Oncol"},{"key":"9365_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.clpt.6100055","volume":"81","author":"L Shi","year":"2007","unstructured":"Shi L, Sings HL, Bryan JT et al (2007) GARDASIL: prophylactic human papillomavirus vaccine development\u2013from bench top to bed-side. Clin Pharmacol Ther 81:259\u2013264. doi: 10.1038\/sj.clpt.6100055","journal-title":"Clin Pharmacol Ther"},{"key":"9365_CR8","unstructured":"SurePath (2005) British Columbia Cervical Cancer Screening Program Feasibility Study: SurePath TM Liquid-Based Cytology: BC Cancer Agency"},{"issue":"Pt 4","key":"9365_CR9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","volume":"76","author":"AM Roda Husman de","year":"1995","unstructured":"de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3\u2032 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057\u20131062. doi: 10.1099\/0022-1317-76-4-1057","journal-title":"J Gen Virol"},{"key":"9365_CR10","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1086\/382896","volume":"189","author":"T Asato","year":"2004","unstructured":"Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Kariya K (2004) A large case\u2013control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 189:1829\u20131832. doi: 10.1086\/382896","journal-title":"J Infect Dis"},{"key":"9365_CR11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00007435-199705000-00011","volume":"24","author":"TK Young","year":"1997","unstructured":"Young TK, McNicol P, Beauvais J (1997) Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian aboriginal and non-aboriginal women. Sex Transm Dis 24:293\u2013298. doi: 10.1097\/00007435-199705000-00011","journal-title":"Sex Transm Dis"},{"key":"9365_CR12","unstructured":"CCSP (2004) British Columbia Cervical Cancer Screening Program 2004 annual report: BC Cancer Agency"},{"key":"9365_CR13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","volume":"297","author":"EF Dunne","year":"2007","unstructured":"Dunne EF, Unger ER, Sternberg M et al (2007) Prevalence of HPV infection among females in the United States. Jama 297:813\u2013819. doi: 10.1001\/jama.297.8.813","journal-title":"Jama"},{"key":"9365_CR14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/(SICI)1096-9071(199602)48:2<210::AID-JMV15>3.0.CO;2-I","volume":"48","author":"DR Brown","year":"1996","unstructured":"Brown DR, Rawlings K, Handy V et al (1996) Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens. J Med Virol 48:210\u2013214. doi: 10.1002\/(SICI)1096-9071(199602)48:2<210::AID-JMV15>3.0.CO;2-I","journal-title":"J Med Virol"},{"key":"9365_CR15","first-page":"513","volume":"163","author":"JW Sellors","year":"2000","unstructured":"Sellors JW, Lorincz AT, Mahony JB et al (2000) Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Cmaj 163:513\u2013518","journal-title":"Cmaj"},{"key":"9365_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/sti.2004.011858","volume":"81","author":"GS Ogilvie","year":"2005","unstructured":"Ogilvie GS, Patrick DM, Schulzer M et al (2005) Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 81:207\u2013212. doi: 10.1136\/sti.2004.011858","journal-title":"Sex Transm Infect"},{"key":"9365_CR17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ijc.10936","volume":"104","author":"TH Pham","year":"2003","unstructured":"Pham TH, Nguyen TH, Herrero R et al (2003) Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 104:213\u2013220. doi: 10.1002\/ijc.10936","journal-title":"Int J Cancer"},{"key":"9365_CR18","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(01)06523-0","volume":"358","author":"X Castellsague","year":"2001","unstructured":"Castellsague X, Menendez C, Loscertales MP et al (2001) Human papillomavirus genotypes in rural Mozambique. Lancet 358:1429\u20131430. doi: 10.1016\/S0140-6736(01)06523-0","journal-title":"Lancet"},{"key":"9365_CR19","first-page":"503","volume":"163","author":"JW Sellors","year":"2000","unstructured":"Sellors JW, Mahony JB, Kaczorowski J et al (2000) Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) group. Cmaj 163:503\u2013508","journal-title":"Cmaj"},{"issue":"3","key":"9365_CR20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.bjc.6604162","volume":"98","author":"VM Coup\u00e9","year":"2008","unstructured":"Coup\u00e9 VM, Berkhof J, Bulkmans NW, Snijders PJ, Meijer CJ (2008) Age-dependent prevalence of 14 high-risk HPV types in The Netherlands: implications for prophylactic vaccination and screening. Br J Cancer 98(3):646\u2013651. doi: 10.1038\/sj.bjc.6604162","journal-title":"Br J Cancer"},{"issue":"1","key":"9365_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1525-1438.2007.00959.x","volume":"18","author":"YP Bao","year":"2008","unstructured":"Bao YP, Li N, Smith JS, Qiao YL, ACCPAB members (2008) Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 18(1):71\u201379","journal-title":"Int J Gynecol Cancer"},{"key":"9365_CR22","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/373901","volume":"187","author":"S Sukvirach","year":"2003","unstructured":"Sukvirach S, Smith JS, Tunsakul S et al (2003) Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 187:1246\u20131256. doi: 10.1086\/373901","journal-title":"J Infect Dis"},{"key":"9365_CR23","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.bjc.6601515","volume":"90","author":"JO Thomas","year":"2004","unstructured":"Thomas JO, Herrero R, Omigbodun AA et al (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 90:638\u2013645. doi: 10.1038\/sj.bjc.6601515","journal-title":"Br J Cancer"},{"key":"9365_CR24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.bjc.6600650","volume":"87","author":"M Molano","year":"2002","unstructured":"Molano M, van den Brule AJ, Posso H et al (2002) Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women. Br J Cancer 87:1417\u20131421. doi: 10.1038\/sj.bjc.6600650","journal-title":"Br J Cancer"},{"key":"9365_CR25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.OLQ.0000080177.82204.E0","volume":"30","author":"S Sanjose de","year":"2003","unstructured":"de Sanjose S, Almirall R, Lloveras B et al (2003) Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 30:788\u2013793. doi: 10.1097\/01.OLQ.0000080177.82204.E0","journal-title":"Sex Transm Dis"},{"key":"9365_CR26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.OLQ.0000085181.25063.6C","volume":"30","author":"E Matos","year":"2003","unstructured":"Matos E, Loria D, Amestoy GM et al (2003) Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 30:593\u2013599. doi: 10.1097\/01.OLQ.0000085181.25063.6C","journal-title":"Sex Transm Dis"},{"key":"9365_CR27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.10825","volume":"103","author":"HR Shin","year":"2003","unstructured":"Shin HR, Lee DH, Herrero R et al (2003) Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 103:413\u2013421. doi: 10.1002\/ijc.10825","journal-title":"Int J Cancer"},{"key":"9365_CR28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Gallus S, Herrero R et al (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366:991\u2013998. doi: 10.1016\/S0140-6736(05)67069-9","journal-title":"Lancet"},{"key":"9365_CR29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/JCM.38.2.651-655.2000","volume":"38","author":"SD Vernon","year":"2000","unstructured":"Vernon SD, Unger ER, Williams D (2000) Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 38:651\u2013655","journal-title":"J Clin Microbiol"},{"key":"9365_CR30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.olq.0000204545.89516.0a","volume":"33","author":"LE Manhart","year":"2006","unstructured":"Manhart LE, Holmes KK, Koutsky LA et al (2006) Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy. Sex Transm Dis 33:502\u2013508. doi: 10.1097\/01.olq.0000204545.89516.0a","journal-title":"Sex Transm Dis"},{"key":"9365_CR31","first-page":"871","volume":"167","author":"JW Sellors","year":"2002","unstructured":"Sellors JW, Karwalajtys TL, Kaczorowski JA et al (2002) Prevalence of infection with carcinogenic human papillomavirus among older women. Cmaj 167:871\u2013873","journal-title":"Cmaj"},{"key":"9365_CR32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/1096-9071(200104)63:4<284::AID-JMV1003>3.0.CO;2-H","volume":"63","author":"JC Feoli-Fonseca","year":"2001","unstructured":"Feoli-Fonseca JC, Oligny LL, Brochu P, Simard P, Falconi S, Yotov WV (2001) Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol 63:284\u2013292. doi: 10.1002\/1096-9071(200104)63:4<284::AID-JMV1003>3.0.CO;2-H","journal-title":"J Med Virol"},{"key":"9365_CR33","first-page":"485","volume":"12","author":"H Richardson","year":"2003","unstructured":"Richardson H, Kelsall G, Tellier P et al (2003) The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 12:485\u2013490","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9365_CR34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.21299","volume":"118","author":"PK Chan","year":"2006","unstructured":"Chan PK, Cheung TH, Tam AO et al (2006) Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118:243\u2013245. doi: 10.1002\/ijc.21299","journal-title":"Int J Cancer"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9365-4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T20:39:14Z","timestamp":1589834354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-009-9365-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,29]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["9365"],"URL":"https:\/\/doi.org\/10.1007\/s10552-009-9365-4","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,29]]}}}